The company's clinical chemistry test uses the NGAL biomarker to determine a patient's risk of acute kidney injury.

Proscia has integrated its Concentriq platform with AWS HealthImaging to provide a cloud-native foundation for pathology.

The submitted test runs on the firm's point-of-care instrument and detects four respiratory pathogens within 10 minutes directly from patient nasal swab samples.